An international research team led by TU Darmstadt Professor Beatrix Süß, working in close collaboration with partners in Germany and Denmark, has elucidated how an RNA switch newly developed at TU Darmstadt recognizes the antibiotic doxycycline and thereby selectively activates or deactivates gene expression. This makes doxycycline a promising basis for synthetic biology and, potentially, for gene therapies as well. The team recently published its findings in Nature Communications.
🛡️
Just a quick checkWe’re checking your connection to prevent automated abuse
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Scientists enable DNA synthesis using only temperature instead of chemical reagents | 7 | 8 | 07-07-2026 |
| 2 | Синтезированы новые молекулы для усиления действия антибиотиков | 0 | 0 | 04-07-2025 |
| 3 | Chemists develop a molecular platform for the selective control of oxygen reaction pathways | 0 | 8.66 | 22-07-2026 |
| 4 | Synthetic Biology Sheds Light on Microbial Evolution | 0 | 7.66 | 31-07-2026 |
| 5 | Molecular electromagnetic sensor may enable remote-controlled gene therapy | 0 | 9.75 | 17-08-2026 |
| 6 | Research Success in the Search for New Reserve Antibiotics | 7 | 8 | 16-07-2026 |
| 7 | New screening tool spots RNA-disrupting antibiotics for drug-resistant gram-negative bacteria | 5 | 7 | 07-07-2026 |
| 8 | This Tiny Bacterial Secret Could Lead to Better Cancer Drugs | 0 | 20.33 | 03-07-2026 |
| 9 | Создана тест-платформа для оценки свойств антибиотиков | 0 | 10.81 | 15-07-2026 |